Last updated on August 2009

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ovarian Cancer
  • Age: Between 21 - 100 Years
  • Gender: Female
  • Other:
    Diagnosis of adnexal mass
    Scheduled to undergo surgical oophorectomy
    Not pregnant or nursing
    Negative pregnancy test
    No known respiratory failure as manifested by signs and symptoms of carbon dioxide
    retention or hypoxemia
    No pulmonary vasculitis
    No known history of severe emphysema
    No known history of pulmonary emboli
    No other condition that causes pulmonary hypertension due to compromised pulmonary
    arterial vasculature
    No known history of severe pulmonary hypertension (i.e., systolic pulmonary artery
    pressures > 90 mm Hg)
    No known history of congenital heart defect that creates a bidirectional or
    right-to-left shunt
    No worsening or clinically unstable congestive heart failure
    No known acute myocardial infarction or acute coronary syndromes
    No known serious ventricular arrhythmias
    Not at high risk for arrhythmia due to prolongation of the QT interval
    No known or suspected hypersensitivity to blood, blood products, or albumin
    No known hypersensitivity to perflutren
    No known or suspected hypersensitivity to octafluoropropane or any other ingredients
    of perflutren lipid microspheres (Definity®)
    No mental status problems, illiteracy, or other circumstance that would preclude
    giving informed consent
    See Disease Characteristics

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.